1 personne sur 3 tombe au moins une fois par an parmi les plus de 65 ans selon l’Assurance Maladie. La salle de bains est ...

Title: Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study Presenter: Marc A. Riedl, M.D., M.S. Format: Poster ...

In parallel, this trial will serve to advance Allarity’s proprietary Drug Response Predictor (DRP ®) companion diagnostic and further evaluate the WNT-modulating mechanism of action unique to ...

FOXO Labs, Inc. is a biotechnology company dedicated to improving human health and life span through the development of cutting-edge technology and product solutions for various industries. For more ...

Following a thorough review process conducted with the assistance of its legal and financial advisors, the Turnstone Board of Directors has unanimously determined that the acquisition by XOMA Royalty ...

Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. For more information on the Russell 3000 ® Index ...

Upon closing, which is expected by early October, Neopharmed Gentili will pay BioCryst $250 million upfront for the European assets and rights related to ORLADEYO, and up to $14 million in future ...

Initiation of commercialization of ProNephro AKITM (NGAL) for diagnostic use in the US ...

Orphalan SA, a global pharmaceutical company focused on rare diseases, is partnering with MAP International and the Wilson Disease Association (WDA) to provide Cuvrior® (trientine tetrahydrochloride) ...

Accèdez sans limite aux 15 000 actualités du site et recevez gratuitement chaque semaine, la Newsletter Santé log avec les actus Santé à ne pas manquer !

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence ...

H.C. Wainwright 4th Annual Kidney Virtual Conference Date: July 14, 2025 Presentation Time: 3:00 pm CEST / 9:00 am EDT Attendees: Frank Weber, CEO; Julia Neugebauer, COO Virtual conference Link to ...